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Abstract 
Background: Liver fibrosis is a public health problem worldwide. There is a need of noninvasive imaging based 
methods for better diagnosis of this disease. In the current study, we aim to evaluate the potential of T1ρ MRI tech-
nique in detecting and characterizing different grades of liver fibrosis in vivo in humans.
Methods: Healthy subjects and patients with liver fibrosis were prospectively recruited for T1ρ MRI of liver on a 1.5 T 
MR scanner. Single slice T1ρ weighted images were acquired at different spin lock duration (0, 10, 20 and 30 ms) with 
spin lock amplitude of 500 Hz in a single breath-hold. Additionally, liver’s T1ρ images were acquired from five healthy 
subjects on the same day (n = 2) and different day (n = 2) sessions for test–retest study. Liver biopsy samples from 
patients were obtained and used to calculate the METAVIR score to define the stage of fibrosis and inflammation 
grade. T1ρ maps were generated followed by computation of mean and standard deviation (SD) values. Coefficient of 
variation (COV) of T1ρ values between two MRI scans was computed to determine reproducibility in liver. T test was 
used to compare T1ρ values between healthy and fibrotic liver. Pearson correlation was performed between stages of 
liver fibrosis and T1ρ values.
Results: The mean (SD) T1ρ value among subject with healthy liver was 51.04 (3.06) ms. The COV of T1ρ values 
between two repetitions in the same day session was 0.83 ± 0.8 % and in different day session was 5.4 ± 2.7 %. T1ρ 
values in fibrotic liver were significantly higher compared to those of healthy liver (p < 0.05). A statically significant 
correlation between stages of fibrosis and T1ρ values was observed (r = 0.99, p < 0.05). Inflammation score for one 
patient was 2 and for remaining patients it was 1.
Conclusions: Proposed T1ρ pulse sequence design and protocol enabled acquisition of a single slice T1ρ weighted 
images in a single breath-hold and hence mitigated breathing motion related artifacts. Preliminary results have 
shown the sensitivity of T1ρ values to changes induced by liver fibrosis, and may potentially be used as a clinical bio-
marker to delineate the stages of liver fibrosis. Further, studies on a large number of subjects are required to validate 
the observations of the current study. Nevertheless, T1ρ imaging can be easily setup on a clinical scanner to monitor 
the progression of liver fibrosis and to the evaluate efficacy of anti-fibrotic drugs.
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Background
Liver cirrhosis and liver cancer are significant health 
problems worldwide. Liver fibrosis, which is due to dam-
age/insults by toxic metabolites and viral infections [1], 
leads to cirrhosis. Chronic hepatitis C, chronic hepatitis 
B, alcoholic liver disease (ALD) and nonalcoholic fatty 
liver disease (NALD) are the most common causes of 
fibrosis progression.
Liver fibrosis is the deposition of excess and abnormal 
extracellular matrix (ECM), known as scar, in the liver in 
response to a variety of chronic liver injuries [1]. These 
matrix proteins include collagens, fibronectin, and pro-
teoglycans. The severity of fibrosis is categorized based 
on the organization of matrix deposition in the liver. 
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Cirrhosis, for example, refers to the end-stage of fibro-
sis in which parenchymal nodules are surrounded by 
scar tissue. Assignment to a specific stage has prognos-
tic value and is important in the management of indi-
vidual patients as well as in trials of potential anti-fibrotic 
agents. Inflammation is another condition that occurs in 
response to liver injury. Detection of early fibrosis offers 
multiple benefits and also aids in assessing disease sever-
ity and treatment response. When identified early, liver 
fibrosis is treatable, even at the stage of cirrhosis by using 
antiviral agents for hepatitis C and B and also taking steps 
to limit alcohol consumption, overweight and reducing 
the incidence of type-2 diabetes mellitus.
Liver biopsy is considered as the gold standard for diag-
nosis of fibrosis. Biopsies, however, carry a risk of signifi-
cant morbidity and mortality [2]. Moreover, biopsies are 
plagued with poor reproducibility and may misclassify 
up to one-third of cirrhotic livers [3]. The limitations of 
biopsies have proven to be significant practical and finan-
cial barriers in clinical care and clinical trials. Existing 
non-invasive diagnostic tests include a variety of serum 
tests and transient elastography [Fibroscan and magnetic 
resonance elastography (MRE)] [4–6]. Among imaging 
methods, MRE have shown some potential in diagno-
sis and staging of liver fibrosis. However, MRE requires 
additional hardware and software, consequently limiting 
their availability in most clinical settings. Double con-
trast MRI using gadolinium chelates and super paramag-
netic iron oxides (SPIOs) was suggested to visualize liver 
fibrosis directly based on the hepatic texture alterations 
[7, 8]. Other MR-based techniques including diffusion-
weighted imaging, MR spectroscopy and magnetization 
transfer (MT) imaging had also shown limited sensitiv-
ity, especially in the early and middle stages of fibrosis [6, 
9–11]. Spin–lattice relaxation time (T1) and spin–spin 
relaxation time (T2) MRI mapping have been used to 
study liver fibrosis. However, the clinical utility of these 
techniques for staging liver fibrosis has yet to be estab-
lished. Research and clinical studies are being carried out 
to evaluate the potential of these techniques for better 
diagnosis as well as clinical feasibility.
Spin lock relaxation time constant in rotating frame 
(T1ρ) MRI technique is another potential technique, 
which can be used for studying liver fibrosis. This tech-
nique has been mainly used for investigating changes 
during knee osteoarthritis [12, 13], myocardial infarc-
tion [14], Alzheimer disease [15]. Recent preclinical study 
[16] on rat liver have shown the potential of T1ρ MRI in 
staging liver fibrosis. Increase in T1ρ values with increase 
in the stage of fibrosis has been reported [16]. The exact 
mechanism behind T1ρ changes in the liver is not very 
clear. As such, excessive accumulation of ECM should 
reduce T1ρ values; however, increase in T1ρ values 
suggests that other factors like inflammation and change 
in exchange rate as well as correlation times might domi-
nate T1ρ contrast in liver fibrosis. A few T1ρ MRI stud-
ies of human liver have been carried in clinical scanners 
[17–19]. These preliminary studies have also shown that 
fibrotic liver exhibits higher T1ρ values compared to 
normal liver. However, these clinical studies have inves-
tigated only late stage fibrosis patients. More T1ρ MRI 
studies are required, with different stage of fibrosis, for 
evaluating the true potential of this technique in the stag-
ing of fibrosis. In addition, a T1ρ MRI pulse sequence 
which enables T1ρ mapping data with reduced breathing 
artifacts is required. As such, in Allkemper et  al.’s study 
respiratory triggering was used, however, it is difficult 
to control small motion displacement between different 
times of spin lock (TSLs) data. In other reported liver 
studies, poor breath holding or respiration induced dis-
placement between different TSLs could be a substantial 
source of error [20]. Acquisition of entire T1ρ map data 
with different TSLs, corresponding to a single slice, in a 
single breath-hold can mitigate motion problems due to 
breathing.
In the current study, we have evaluated the potential of 
T1ρ MRI technique in the diagnosis of human patients 
with liver fibrosis. We implemented a spin locked MRI 
pulse sequence for T1ρ mapping of human liver in vivo 
on a 1.5  T clinical scanner and evaluated the feasibil-
ity of proton T1ρ relaxation mapping in detecting and 
quantifying changes due to liver fibrosis. Proposed pulse 
sequence enables acquisition of single 2D slice T1ρ MRI 
data with different TSLs in a single breath-hold. T1ρ val-
ues of patients were compared with histological staging 
and inflammation score of the liver in patients.
Methods
Fourteen subjects, seven healthy (age = 27–65 years old) 
and seven patients (age  =  40–70  years old) with liver 
fibrosis underwent MRI on 1.5  T clinical scanners (Sie-
mens Medical Systems, Malvern, PA, USA). All the liver 
patients were diagnosed with chronic hepatitis C. The 
study protocol was approved by the Institutional Review 
Board of the institute and all subjects provided written 
informed consent. Subjects were positioned in the bore 
of the magnet, headfirst supine, with the body array coil 
placed superiorly and the vendor-supplied spine array 
coil located inferiorly. All the subjects were instructed to 
provide a gap of around 3 h between meal and MRI scan.
To minimize breathing related motion artifacts, MRI 
data were acquired during breath-hold. A gap of around 
20  s was provided before starting next MRI acquisition. 
Imaging started with a tri-plane localizer followed be reg-
ular clinical anatomical imaging sequences, including T1- 
and T2-weighted imaging. For T1ρ imaging, an axial slice 
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in the center of the liver was selected guided by anatomi-
cal T2 weighted images. T1ρ pulse sequence consisted of 
two parts: spin-lock pulse cluster and segmented turbo-
flash readout with a spoiler for each part. T1ρ pulse clus-
ters consist of 90°(+x) − SL(+y) − 180°(+y) − SL(−y) − 
90°(−x) pulse [21], where SL represents spin lock. This is 
an optimized version of basic T1ρ pulse clusters [22] to 
account for B0 inhomogeneity. The SL pulse consists of 
spin lock amplitude, B1sl (= (γB1/2π) = ω1/2π) and spin 
lock duration (TSL). Parameter γ represent Gyromag-
netic ratio, ω1 represents frequency. In order to retain 
maximum T1ρ weighting and minimizing the T1 recov-
ery, centric encoding was implemented.
T1ρ imaging protocol T1ρ imaging was performed with 
spin lock duration (TSL)  =  0, 10, 20, 30  ms, spin lock 
pulse amplitude B1sl  =  500  Hz, TR/TE  =  5.1/2.4  ms, 
flip angle  =  10°, FOV  =  300  ×  300  mm2, matrix 
size =  128 ×  128, slice thickness =  10  mm, number of 
shots = 1. The delay between successive T1ρ clusters was 
set to 2.5 s. The data corresponding to a single slice and 
four TSLs were acquired during one breath-hold period 
(scan time = ~12 s).
Before acquiring final data from subjects, the T1ρ 
imaging protocol was optimized in term of scan time 
and numbers of TSLs. Maximum TSL was limited by the 
scanner. Reproducibility studies were also performed on 
five healthy subjects. Two data sets in the same day MRI 
session (5  min gap) and different day MRI session were 
acquired for testing reproducibility of T1ρ mapping.
Liver Histology The biopsy specimens from each 
patient were obtained and fixed in a formalin solution 
and embedded in paraffin. Immunohistochemistry was 
performed to calculate the METAVIR score. Following 
METAVIR score [23] were used by Pathologists for stag-
ing liver fibrosis (F): 0 = no scarring; 1 = minimal scar-
ring; 2 = scarring has occurred and is inside the areas of 
the liver including, blood vessels; 3  =  bridging fibrosis 
(the fibrosis is spreading and connecting to other areas 
that contain fibrosis); 4  =  cirrhosis or advanced scar-
ring of the liver. Additionally, following grades, based 
upon METAVIR scoring [24], were used for determin-
ing inflammation activity (A) in liver biopsy specimens: 
0 = no; 1 = mild; 2 = moderate; 3 = sever inflammation.
Image Processing and Data Analysis Liver tissue was 
manually segmented on T1ρ-weighted MRI image cor-
responding to TSL = 30 ms. The choice of T1ρ W image 
corresponding to longest TSL was based upon the obser-
vation that areas with any B0/B1 inhomogeneity artifacts 
are better visible on T1ρ W image corresponding to 
long TSL. Therefore, areas corresponding to these B0/B1 
inhomogeneity artifacts can be easily avoided. Moreo-
ver, longest TSL in the current study was only 30 ms, so 
SNR was fairly good for segmentation. The T1ρ-weighted 
(T1ρ-W) data signal (S(TSL)) corresponding to four 
TSLs were fitted voxel-wise to mono-exponential decay 
expression, S(TSL) = S(0) ∗ exp(−TSL/T1ρ), for com-
puting T1ρ values using an in-house written code in 
MATLAB (2007b). Coefficient of determination (R2) was 
used to determine quality of exponential function fit and 
voxels with R2 less than 0.8 were excluded from T1ρ map 
of liver. Mean and standard deviation (SD) of T1ρ val-
ues were computed for a single region of interest (ROI) 
on liver tissue, excluding any visible blood vessel voxels, 
from all the data. The size and location of ROI on T1ρ 
map was kept similar across all the subjects. T1ρ color 
maps of manually segmented liver sections were overlaid 
on baseline gray scale images (TSL =  0). Coefficient of 
variation (COV) for repeatability test was determined as 
ratio of SD to mean value of two measurements for each 
subject’s data. COV was calculated for the same ROI as 
mentioned above. Final COV was reported as average 
value of COVs for five subjects.
Student’s T-test was performed to compare T1ρ 
values between healthy and fibrotic livers. For studying 
correlation between T1ρ values vs stage of fibrosis, 
subject’s data were divided into four groups based 
upon the stage of fibrosis on the basis of histological 
information on patients. All healthy volunteer’s data 
were considered into group-0, subjects with stage-1 
fibrosis in group-1, subjects with stage-2 in group-2 
and subjects with stage-3 or 4 in group-3. Bar plots of 
liver T1ρ values were plotted against different groups. 
Correlation between T1ρ values of fibrotic liver and 
stage of fibrosis was computed. Relationship between 
T1ρ values of fibrotic liver and inflammation score was 
also studied.
Results
Average T1ρ value along with inter subject SD in healthy 
liver was 51.04 ± 3.06 ms. T1ρ-W (TSL = 30 ms) image 
and T1ρ map from healthy liver are shown in Fig.  1. 
Average T1ρ values in ROI marked on liver in Fig. 1a is 
55.6 ms. T1ρ values in voxels containing large blood ves-
sels were set to zero based on poor R2 (<0.8) value. B0 
and B1 field inhomogeneity artifacts appeared on T1ρ 
weighted images of some subjects, particularly on the 
edges close to heart. Usually these voxels exhibited poor 
fit and were excluded from the main analysis. While some 
of the voxels containing blood vessels can still be visual-
ized as high T1ρ values compared to normal liver tissue 
and these might interfere with interpretation of results. 
To avoid this problem ROIs were carefully drawn in liver 
tissue, excluding any visible blood vessel voxel. The COV 
of T1ρ values between two repetitions in the same day 
session was 0.83 ± 0.8 % and in different day session was 
5.4 ± 2.7 %.
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In the current study, following fibrosis scores were 
observed: 0 for one patient; 1 for two patients; 2 for three 
patients; 3 for one patient and 4 for one patient. For 
healthy subject data fibrosis score were not available. In 
the current study, we assumed fibrosis score of zero for 
healthy subjects data. An inflammation score of 2 for one 
patient and 1 for remaining patients was observed.
T1ρ maps of another healthy subject (Fig.  2a) and 
patients with different fibrosis stage-1, 2, 3 and 4 are 
shown in Fig.  2. All of the patients had a same inflam-
mation score (score = 1). Elevated T1ρ values in fibrotic 
livers are observed compared to the healthy liver. T1ρ 
maps of healthy subject, stage-1 and stage-2 (Fig.  2a–c) 
are homogeneous compared to stage-3 and 4 (Fig. 2d, e), 
excluding blood vessels. White arrow points to the areas 
having possible field inhomogeneity artifacts.
Bar plot of T1ρ values corresponding to different 
groups (fibrosis grades) is shown in Fig.  3. T1ρ values 
were 51.0 ± 3.0, 59.2 ± 2.5, 64.2 ± 4.5 and 69.9 ± 5.4 ms 
in healthy, stage-1, stage-2 and stage-3 and 4 respectively. 
T1ρ values in fibrotic liver were significantly (p  <  0.05) 
higher compared to a healthy liver. Inter subject vari-
ations of T1ρ values are reflected by error bars. A high 
correlation (coefficient of correlation  =  0.99) between 
T1ρ and fibrosis staging was observed. T1ρ values 
(mean ± SD) for all the patients along with fibrosis score 
and inflammation grades are shown in Table 1.
Figure 4 show T1ρ map of patient, having stage-0 fibrosis 
and inflammation grade equal to 1, based upon METAVIR 
scale. For this subject elevated T1ρ values were observed 
all across the liver compared to healthy subject’s liver. In 
fact T1ρ value for this subject was higher compared to 
average values in group-3 also. However, the overall T1ρ 
map of liver, except blood vessels, was homogeneous. Dur-
ing analysis, in stage-0 we have included all the healthy 
subjects and this subject’s data was excluded from analysis.
Discussion
In the current study, the feasibility of single slice T1ρ map-
ping of liver in a single breath-hold was demonstrated on 
1.5 T clinical scanner and preliminary data from healthy 
and fibrotic human liver is presented along with histolog-
ical results from fibrotic livers. Preliminary results from 
current studies have shown the potential of differenti-
ating between healthy and fibrotic livers. These results 
are in agreements with recently reported T1ρ studies in 
liver [17, 18]. Previous reported studies have included 
data only from late stage fibrosis and healthy subjects. 
In the current study, data from healthy as well as fibrotic 
liver corresponding to different stage of fibrosis have 
been included. Preliminary results from current studies 
have also shown a high correlation between the stage of 
fibrosis and T1ρ values. However, the number of subjects 
in different stages of fibrosis were small and therefore 
further studies on more subjects need to be performed 
for conforming the current observations. In the current 
study, inflammation score for all patients was equal to 
1 except for one subject it was 2. For healthy subjects, 
it was assumed to be equal to 0. Increase in fluid level 
should increase T1ρ values and which was also reflected 
by higher T1ρ values in the patients data compared to 
healthy liver. However, this change in inflammation score 
is poorly correlated with an increase in fibrosis. This 
might be due to the fact that during liver fibrosis, other 
mechanisms such as change in ECM also take place.
Breathing induced motions, which could result in erro-
neous T1ρ mapping, were avoided by collecting T1ρ data 
corresponding to multiple TSLs in a single breath-hold 
period. Design and protocol of T1ρ pulse sequence used 
in the current study enabled collection of entire T1ρ data, 
required for generation of T1ρ map, in a single breath-
hold period of ~12  s. T1ρ data corresponding to multi-
ple slices can be collected in a similar manner during 
Fig. 1 T1ρ MRI weighted image corresponding to TSL = 30 ms (a) and map (b) of healthy human liver. T1ρ map of segmented liver is color overlaid 
on anatomical image. T1ρ value in ROI marked on weighted image (a) is 55.6 ± 2.3 ms
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different breath-hold periods. In the current study, we 
have presented data corresponding to single slice. In 
most cases of chronic liver diseases causing fibro-
sis, such as viral and autoimmune hepatitis, as well as 
steatohepatitis, affect the liver in a relatively uniform way 
[25]. In the current study, all the patients were diagnosed 
with chronic hepatitis C. Therefore, the results of the cur-
rent study should not be affected by choice of mismatch 
between biopsy location and imaging slice or a single 
ROI results. Therefore, results from a single slice of liver 
should be sufficient for the initial demonstration pur-
pose. Moreover, it is feasible to apply the same approach 
to acquire data from multiple slices. In fact, we did col-
lect T1ρ data corresponding to multiple slices (n  =  8) 
Fig. 2 T1ρ maps of healthy human liver (a) and patients liver corresponding to fibrosis stage of 1, 2, 3 and 4 respectively. Maps of segmented liver 
are color overlaid on anatomical image. White arrows point to the areas with possible field inhomogeneity artifacts
Fig. 3 Bar graph of T1ρ values corresponding to different groups 
based upon fibrosis stage. Group-0 contains healthy subjects, 
group-1 contains stage-1 fibrosis, group-2 contains stage-2 fibrosis 
and group-3 contains stage-3 or 4 fibrosis. Fibrosis score are based 
upon METAVIR scale (0–4)
Table 1 T1ρ values (mean  ±  SD) for  all the patients 
along  with fibrosis score and  inflammation grades based 
upon METAVIR score
Patient number Fibrosis score Inflammation grade T1ρ (ms)
1 0 1 73.0 ± 3.7
2 1 1 57.4 ± 3.2
3 1 1 61.0 ± 3.5
4 2 2 60.7 ± 3.7
5 2 1 67.7 ± 5.4
6 3 1 66.1 ± 5.0
7 4 1 73.8 ± 6.4
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for some subjects. This data was collected in multiple s, 
a single slice data (4 T1ρ W images) per breath hold was 
collected. Since multiple slice data was not collected for 
all the subjects, we have not included the results of multi-
slice T1ρ mapping in the current study.
Another, challenge in liver imaging is extensive vascula-
ture of the liver parenchyma. Computation of T1ρ values 
in voxels containing vasculature is erroneous due to flow 
as well as the use of short TSLs. The majority of voxels 
in or containing large blood vasculature were removed 
based upon R2 values; however, voxels containing small 
vasculature were present in final T1ρ maps. T1ρ values 
in these voxels are not reliable and therefore these voxels 
should not be considered in the final analysis. To avoid 
this problem, we have presented T1ρ values from a small 
ROI excluding voxels with any visible vasculature.
T1ρ values were reproducible as demonstrated by small 
COV values for T1ρ in two different time experiments. 
Moreover, variations (SD) of ~3  ms (which is ~6  % of 
mean value) were observed among healthy subjects aver-
age T1ρ values.
In the current study, have used Pearson correlation 
coefficient for assessing correlation between T1ρ values 
and fibrosis score. Reported preliminary studies on T1ρ 
in liver have shown higher T1ρ values for fibrotic liver. 
For simplicity we have assumed a linear increase and that 
is the reason for use of Pearson correlation. As such, T1ρ 
values for stage-4 (74 ms) are higher compared to stage-3 
(66  ms); however, due to only one subject for each of 
these two stages we have combined results of stage-3 and 
4.
In the current study, we have scanned subjects over 
a wide age range. Aging results change in liver at both 
structural and functional level [26]. However, recently 
published study [17] have shown no relevant correlation 
between T1ρ values and age in liver.
Segmented turbo-flash readout has an advantage in 
terms of reduction in SAR deposition and fast imag-
ing. However, flash readout can reduce T1ρ contrast, 
due to T1 recovery. In order to preserve maximum true 
T1ρ contrast, we used a centric encoding scheme in the 
current study and acquired only 128 lines during a sin-
gle shot. This number was chosen based upon temporal 
resolution and T1ρ contrast preservation.
Depending on the tissue under consideration, correc-
tion of B0 and B1 field inhomogeneities and a proper com-
bination of B1sl amplitude and SL duration is required 
for accurate computation of T1ρ map. Liver tissues have 
high field inhomogeneities, and automatic or interactive 
shimming does not work well in liver tissue. In recent 
years, significant attempts have been made in T1ρ tech-
nique implementation to minimize B1 and B0 inhomo-
geneities [21, 22]. Inclusion of a 180° pulse in T1ρ pulse 
cluster elevates SAR, although it minimizes the artifacts 
that can arise from B0 field inhomogeneities. In spite of 
use of this B0 and B1 field inhomogeneity compensation 
pulse cluster, some artifacts were observed in the voxels 
on liver particularly close to the lung. For reducing SAR 
accumulation, low SAR readout option has been used in 
the current study. There may be small errors associated 
with T1ρ estimation as we have used TSLs of only up to 
30 ms.
Conclusions
In conclusion, T1ρ mapping of human liver is feasible 
within SAR limits on 1.5 T clinical scanner. Proposed T1ρ 
pulse sequence design and protocol enabled the acquisi-
tion of entire T1ρ data of a single slice, corresponding to 
4 TSLs, in a single breath-hold period and hence miti-
gated breathing motion related artifacts. Preliminary T1ρ 
MRI results suggest the potential of using T1ρ values 
in the diagnosis of liver fibrosis. Data acquisition from 
Fig. 4 T1ρ weighted image corresponding to TSL = 30 ms (a) and map (b) of patient liver having stage-0 fibrosis and inflammation grade equal 
to 1. T1ρ map of segmented liver is color overlaid on anatomical image. T1ρ values in ROI marked on weighted image (a) is 73 ± 9 ms. White arrow 
points to liver tissue with partial volume to kidney
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a large pool of patients, with different stages of fibrosis, 
is required before making any final conclusions on the 
potential use of T1ρ MRI for diagnosis and staging of 
liver fibrosis.
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